Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2004 Jul 16;14(14):3715-20.

Structure-based design of amidinophenylurea-derivatives for factor VIIa inhibition.

Author information

1
Aventis Pharma Deutschland GmbH, Building G878, D-65926 Frankfurt, Germany. otmar.klinger@aventis.com

Abstract

The amidinophenylurea scaffold was earlier shown to provide an excellent template for the synthesis of novel and potent inhibitors of the blood coagulation factor VIIa. In this contribution we describe the structure-based design of potent ligands guided by X-ray crystallography, molecular modeling and docking studies. The design and synthetic efforts were directed towards novel modifications to explore the protease binding region close to the S4 subsite.

PMID:
15203149
DOI:
10.1016/j.bmcl.2004.05.006
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center